Is STTK or SXTC more undervalued in 2026?

CirclFi compares Shattuck Labs, Inc. (STTK) and China SXT Pharmaceuticals, Inc. (SXTC) using 13 institutional-grade valuation models. STTK has a Quality of Company score of 5.8/10 while SXTC scores 1.1/10.

Which is a better buy — STTK or SXTC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do STTK and SXTC valuations compare?

STTK at $5.95 and SXTC at $1.67 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

STTK vs SXTC Valuation Comparison 2026 — Intrinsic Value Analysis

STTK

Pharmaceutical Preparations

Shattuck Labs, Inc.

Quality

5.8

out of 10

Value Trap

SAFE

Price

$5.95

Last close

Models

9/13

Active

SXTC

Pharmaceutical Preparations

China SXT Pharmaceuticals, Inc.

Quality

1.1

out of 10

Value Trap

SAFE

Price

$1.67

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	STTK Fair Value	STTK Upside	SXTC Fair Value	SXTC Upside
Bayesian DCF	Intrinsic	$2.25	-62.3%	$0.20	-87.8%
Earnings Power Value	Intrinsic	—	—	$4.60	+122.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.97	-66.8%	—	—
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for STTK vs SXTC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

STTK vs SXTC — Which Stock Is More Undervalued?

STTK scores higher with a 5.8/10 quality rating vs SXTC's 1.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Shattuck Labs, Inc. (STTK) and China SXT Pharmaceuticals, Inc. (SXTC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

STTK currently trades at $5.95 with a QOC of 5.8/10, while SXTC trades at $1.67 with a QOC of 1.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).